NHNegar Heydari

Negar Heydari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Negar Heydari has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ameliorating Effects of Curcumin on Testicular Cancer

    by Reza Arefnezhad, Pouya Goleij, Negar Heydari, Fatemeh Rezaei-Tazangi, Hossein Motedayyen

    In the young men’s population, testicular cancer (TC) is characterized as one of the main causes of morbidity and mortality around the world. This cancer is mainly divided into germ cell and nongerm cell types and manifests different signs and symptoms, like bone pain, nausea, lower back pain, and anorexia. Also, TC is associated with serious conditions, such as urogenital disorders, infertility, cardiovascular diseases, and solid tumors. Unfortunately, common remedies for TC, including chemotherapy and surgery, have not provided a promising outlook due to their adverse effects on life quality. Ergo, finding a new therapeutic candidate with high effectiveness and low detrimental impacts is indispensable. Newly, herbal remedies have attracted much interest because of their potential to improve diverse diseases, like cancer. In this context, increasing evidence indicated that curcumin, as a polyphenol compound originating from the plant Curcuma longa, has beneficial effects for treating TC. Hence, in this narrative review, we aimed to review documents showing the therapeutic potential of this herbal candidate against TC.


  • Preparation of novel 2-(2-oxo-2H-chromen-4-yl)-3- arylthiazolidin-4-one derivatives using an efficient ionic liquid catalyst

    by Majid Ghashang, Hadi Taghrir, Mohammad Najafi Biregan, Negar Heydari, Fateme Azimi

    An eco-friendly procedure for synthesis of 2-(2-oxo-2H-chromen-4-yl)-3-arylthiazolidin-4-one derivatives by three-component reaction of 2-oxo-2H-chromene-4-carbaldehydes, aromatic amines and thioglycolic acid, with tetramethylbutane-1,4-diammonium acetate as a low-cost ionic liquid catalyst under reflux condition is described. The use of an ionic liquid as a catalyst has the advantages of high yields, short reaction time and environmentally friendly reaction media.